Cargando…

Mapping chromatin accessibility and active regulatory elements reveals pathological mechanisms in human gliomas

Chromatin structure and accessibility, and combinatorial binding of transcription factors to regulatory elements in genomic DNA control transcription. Genetic variations in genes encoding histones, epigenetics-related enzymes or modifiers affect chromatin structure/dynamics and result in alterations...

Descripción completa

Detalles Bibliográficos
Autores principales: Stępniak, Karolina, Machnicka, Magdalena A., Mieczkowski, Jakub, Macioszek, Anna, Wojtaś, Bartosz, Gielniewski, Bartłomiej, Poleszak, Katarzyna, Perycz, Malgorzata, Król, Sylwia K., Guzik, Rafał, Dąbrowski, Michał J., Dramiński, Michał, Jardanowska, Marta, Grabowicz, Ilona, Dziedzic, Agata, Kranas, Hanna, Sienkiewicz, Karolina, Diamanti, Klev, Kotulska, Katarzyna, Grajkowska, Wiesława, Roszkowski, Marcin, Czernicki, Tomasz, Marchel, Andrzej, Komorowski, Jan, Kaminska, Bozena, Wilczyński, Bartek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8206121/
https://www.ncbi.nlm.nih.gov/pubmed/34131149
http://dx.doi.org/10.1038/s41467-021-23922-2
Descripción
Sumario:Chromatin structure and accessibility, and combinatorial binding of transcription factors to regulatory elements in genomic DNA control transcription. Genetic variations in genes encoding histones, epigenetics-related enzymes or modifiers affect chromatin structure/dynamics and result in alterations in gene expression contributing to cancer development or progression. Gliomas are brain tumors frequently associated with epigenetics-related gene deregulation. We perform whole-genome mapping of chromatin accessibility, histone modifications, DNA methylation patterns and transcriptome analysis simultaneously in multiple tumor samples to unravel epigenetic dysfunctions driving gliomagenesis. Based on the results of the integrative analysis of the acquired profiles, we create an atlas of active enhancers and promoters in benign and malignant gliomas. We explore these elements and intersect with Hi-C data to uncover molecular mechanisms instructing gene expression in gliomas.